why Moderna Inc [MRNA] is a Good Choice for Investors After New Price Target of $129.39
Moderna Inc [NASDAQ: MRNA] jumped around 0.58 points on Wednesday, while shares priced at $85.95 at the close of the session, up 0.68%. The company report on February 7, 2024 at 9:14 AM that Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of